Thiazole and pyrazole derivaties as Flt3 kinase inhibitors
Details for Australian Patent Application No. 2009202639 (hide)
International Classifications
Event Publications
16 July 2009 Complete Application Filed
23 July 2009 Application Open to Public Inspection
Published as AU-A-2009202639
30 July 2009 Corrigenda
Applications OPI - Name Index Under the name Novartis AG, Application No. 2009202639, under INID (54), correct the invention title to read Thiazole and pyrazole derivatives as Flt-3 kinase inhibitors Specifications Republished The following specifications contained errors when advertised OPI, Accepted or Certified. They have been reissued on the AU-A or AU-B CD-ROM of this Journal date. 2002101059 Maia, E. 2002319453 University College Cardiff Consultants Limited 2003211381 Ono Pharmaceutical Co., Ltd. 2003
9 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2009202640-Telephone for sending voice and text messages
2009202638-System for storing and dispensing delineation devices
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser